Interview with John Norman, Country Manager, Nycomed South Africa
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
Address: PO Box 651761
Tel: +27 11 777 7500
SAMED’s mission is to safeguard and promote the interests of our members, to encourage ethical principles and practices, promote innovation and better patient outcomes and ensure effective representation with all relevant authorities whether public or private.
Objectives of the association include:
Ensuring that all activities of the company shall have the best interests of its members as the primary objective, provided that such shall not unreasonably diminish from the needs and rights of patients;
Providing a forum for discussion on matters affecting the manufacturers and distributors of medical and surgical products in South Africa;
Promoting and encouraging among members ethical principles and practices, voluntarily agreed upon, and to this end, publish a Code of Business Practice which shall be binding on all members;
Communicate and represent, through an elected committee of members, the industry’s standpoint on relevant matters and offer advice or make recommendations when the need arises to any body or institution whose decisions and policies might affect the industry;
Co-operating with governments and regulatory authorities, whether national or international, as appropriate;
Working towards harmonization of standards and regulatory requirements within the area of medical devices manufacture and supply;
and Promoting a spirit of co-operation and shared responsibility among public and private health care professionals and providers, which shall include the State, as well as other relevant sectors, within the context of effective, efficient and transparent health care delivery.
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
See our Cookie Privacy Policy Here
